Search bioRxiv⌕ Search

Biology subjects

Moreno, M. R.

Publications and source records attributed to Moreno, M. R..

2 recordsLinked to original sources

Bioelectric and Epigenetic Landscapes in Lateralized Breast Tumors Reveal Distinct Tumor Microenvironment Signatures.

Breast cancer heterogeneity is shaped not only by intrinsic tumor properties but by the surrounding microenvironment (TME). Here we report a left-right (L-R) asymmetry in the breast TME associated to tumor features. Bioinformatic analysis of TCGA RNA-seq and histological data revealed that R-sided tumors display higher stromal scores and are cancer-associated fibroblasts (CAFs) signatures. This difference was validated in paired L-R PDX and xenograft models, in which R-sided tumors showed increased -SMA expression. The asymmetry extended to tumor bioelectricity: across PDX and xenograft models, and in cells cultured with L- or R-conditioned media, L-sided tumors consistently displayed a more depolarized membrane potential than their R counterparts. In vitro, this bioelectric difference was methylation-dependent - abolished by the DNA methyltransferase inhibitor decitabine -and reversible when the laterality of the conditioned media was inverted. Methylome analysis of animal models identified the gap--unction gene GJA1 as significantly hypermethylated in L-sided tumors, accompanied by reduced expression of connexin genes. A computational model showed that membrane potential and methylation form two stable states, depending on gap-junction coupling strength. Together, these findings identify L-R asymmetry as an overlooked layer of breast tumor heterogeneity that integrates stromal, bioelectric, and epigenetic features. This framework may extend to other paired organs and suggests that tumor laterality could have biological and therapeutic relevance.

cancer biology↗

Tau-mediated axonal degeneration is prevented by activation of the WldS pathway

Tauopathy is characterised by neuronal dysfunction and degeneration occurring as a result of changes to the microtubule associated protein tau. The neuronal changes evident in Tauopathy bear striking morphological resemblance to those reported in models of Wallerian degeneration. The mechanisms underpinning Wallerian degeneration are not fully understood although it can be delayed by the expression of the slow Wallerian degeneration (WldS) protein, which has also been demonstrated to delay axonal degeneration in some models of neurodegenerative disease. Given the morphological similarities between tauopathy and Wallerian degeneration, this study investigated whether tau-mediated phenotypes can be modulated by expression of WldS. In a Drosophila model of tauopathy in which expression of human Tau protein (hTau0N3R) leads to progressive age-dependent phenotypes, activation of the pathway downstream of WldS completely suppressed tau-mediated degeneration. This protective effect was evident even if the pathway downstream of WldS was activated several weeks after hTau-mediated degeneration had become established. In contrast, WldS expression without activation of the downstream protective pathway did not rescue tau-mediated degeneration in adults or improve tau-mediated neuronal dysfunction including deficits in axonal transport, synaptic alterations and locomotor behaviour in hTau0N3R -expressing larvae. This collectively implies that the pathway mediating the protective effect of WldS intersects with the mechanism(s) of degeneration initiated by hTau and can effectively halt tau-mediated degeneration at both early and late stages. Understanding the mechanisms underpinning this protection could identify much-needed disease-modifying targets for tauopathies.

neuroscience↗